These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27659504)

  • 1. Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?
    Bournia VK; Kitas G; Protogerou AD; Sfikakis PP
    Mod Rheumatol; 2017 Jul; 27(4):559-569. PubMed ID: 27659504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk profile of antirheumatic agents in patients with osteoarthritis and rheumatoid arthritis.
    Nurmohamed MT; van Halm VP; Dijkmans BA
    Drugs; 2002; 62(11):1599-609. PubMed ID: 12109923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
    Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
    Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK.
    Moore A; Phillips C; Hunsche E; Pellissier J; Crespi S
    Pharmacoeconomics; 2004; 22(10):643-60. PubMed ID: 15244490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis.
    Tachecí I; Bradna P; Douda T; Baštecká D; Kopáčová M; Rejchrt S; Lutonský M; Soukup T; Bureš J
    Rheumatol Int; 2016 Nov; 36(11):1557-1561. PubMed ID: 27549792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.
    Lin TC; Solomon DH; Tedeschi SK; Yoshida K; Kao Yang YH
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
    Lee MC; Lee S; Suh DC; Kim J; Kong SX;
    Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
    Cannon CP; Curtis SP; FitzGerald GA; Krum H; Kaur A; Bolognese JA; Reicin AS; Bombardier C; Weinblatt ME; van der Heijde D; Erdmann E; Laine L;
    Lancet; 2006 Nov; 368(9549):1771-81. PubMed ID: 17113426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nabumetone: a new NSAID for rheumatoid arthritis and osteoarthritis.
    Roth SH
    Orthop Rev; 1992 Feb; 21(2):223-7. PubMed ID: 1538889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.
    Zingler G; Hermann B; Fischer T; Herdegen T
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1479-1492. PubMed ID: 27575590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritis.
    Nawaz H; Ali A; Rehman T; Aslam A
    Clin Rheumatol; 2021 May; 40(5):1767-1778. PubMed ID: 33009599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United States.
    Coyne KS; Margolis MK; Cappelleri JC; Hsieh R; Essex MN; Park PW; Joshi AV
    Curr Med Res Opin; 2013 May; 29(5):421-33. PubMed ID: 23444970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients.
    Wolfe F; Hawley DJ
    J Rheumatol; 2000 Jul; 27(7):1668-73. PubMed ID: 10914849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
    Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ
    Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
    Greenberg JD; Bingham CO; Abramson SB; Reed G; Sebaldt RJ; Kremer J
    Arthritis Rheum; 2005 Feb; 53(1):12-7. PubMed ID: 15696570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis.
    Cryer B; Luo X; Assaf AR; Sands G; Mardekian J
    Curr Med Res Opin; 2011 Feb; 27(2):295-302. PubMed ID: 21142617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overuse of prescription and OTC non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis.
    Cavagna L; Caporali R; Trifiro G; Arcoraci V; Rossi S; Montecucco C
    Int J Immunopathol Pharmacol; 2013; 26(1):279-81. PubMed ID: 23527735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of non-steroidal anti-inflammatory drugs on faecal flora and bacterial antibody levels in rheumatoid arthritis.
    Dearlove SM; Barr K; Neumann V; Isdale A; Bird HA; Gooi HC; Wright V
    Br J Rheumatol; 1992 Jul; 31(7):443-7. PubMed ID: 1628165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis.
    Dessein PH; Stanwix AE; Joffe BI
    Arthritis Res; 2002; 4(5):R5. PubMed ID: 12223108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication.
    Braun J; Baraliakos X; Westhoff T
    Semin Arthritis Rheum; 2020 Apr; 50(2):285-288. PubMed ID: 31439354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.